Chiara Carlomagno
- Oncology top 0.5%
- Cancer Research top 1%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Sabino De PlacidoMichelino De LaurentiisSara LonardiStefano PepeGianluca TomaselloSilvana ChiaraAlberto ZaniboniAlfredo Falcone
- Topics
- Colorectal Cancer Treatments and Studies (35 papers)Cancer Treatment and Pharmacology (25 papers)Gastric Cancer Management and Outcomes (17 papers)
- Cited by
- OncologyCancer ResearchHepatology
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Chiara Carlomagno
96 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 3.4k
- Cancer Research 1.2k
- Pulmonary and Respiratory Medicine 1.1k
- Molecular Biology 1.0k
- Pathology and Forensic Medicine 805
Countries citing papers authored by Chiara Carlomagno
This map shows the geographic impact of Chiara Carlomagno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Carlomagno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Carlomagno more than expected).
Fields of papers citing papers by Chiara Carlomagno
This network shows the impact of papers produced by Chiara Carlomagno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Carlomagno. The network helps show where Chiara Carlomagno may publish in the future.
Co-authorship network of co-authors of Chiara Carlomagno
This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Carlomagno. A scholar is included among the top collaborators of Chiara Carlomagno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Carlomagno. Chiara Carlomagno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 37 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 1 | |
| 6 | 22 | |
| 7 | 5 | |
| 8 | 91 | |
| 9 | 140 | |
| 10 | 65 | |
| 11 | 8 | |
| 12 | 66 | |
| 13 | Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. | 101 |
| 14 | 2 | |
| 15 | Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up. | 10 |
| 16 | 328 | |
| 17 | 28 | |
| 18 | 4 | |
| 19 | 156 | |
| 20 | 24 |
About Chiara Carlomagno
Chiara Carlomagno is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 99 papers that have together received 4.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (35 papers), Cancer Treatment and Pharmacology (25 papers) and Gastric Cancer Management and Outcomes (17 papers). The work is most often cited by research in Oncology (3.4k citations), Cancer Research (1.2k citations) and Hepatology (516 citations). Chiara Carlomagno has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Sabino De Placido, Michelino De Laurentiis, Sara Lonardi, Stefano Pepe, Gianluca Tomasello, Silvana Chiara, Alberto Zaniboni, Alfredo Falcone, Fotios Loupakis and Giuseppe Tonini. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.